2011-03-15

Technolas Perfect Vision Receives FDA Approval of Latest Technology for Custom LASIK

MUNICH, GERMANY--(Marketwire - March 14, 2011) - Technolas Perfect Vision GmbH (TPV), a cataract and refractive laser company at the forefront of providing advanced eye laser treatments, today announced that the U.S. Food and Drug Administration (FDA) has approved the ZYOPTIX® Advanced Nomogram. The Advanced Nomogram is the latest, state-of-the-art methodology for use in custom LASIK eye surgery procedures when treating nearsightedness and astigmatism. This confirms that "there is convincing evidence that LASIK myopia corrections are more accurate with the Advanced Nomogram than without it."

Using the Advanced Nomogram when performing custom LASIK with the TECHNOLAS 217z100 laser, significantly improves the predictability of the results, as well as reducing the possibility of requiring a second enhancement procedure. Technolas Perfect Vision is the ONLY company in the US able to offer this latest, approved technology for LASIK on their laser platform.

The Advanced Nomogram was developed in collaboration with the Center for Visual Science, at the University of Rochester Flaum Eye Institute.

source: Technolas Perfect Vision